Management of hypertension in pregnancy: A review
Journal Title: Journal of Pharmacy Research - Year 2011, Vol 4, Issue 5
Abstract
Hypertension in pregnancy is the most common cause of maternal death, with a risk of approximately 10 deaths / million pregnancies in the UK. Hypertension in pregnancy is also the most common cause of stillbirth and neonatal death. Globally, hypertension is the most important risk factor for cardiovascular diseases. In around 5% of people with hypertension, the high blood pressure is explained by underlying renal or adrenal diseases. In the remaining 95%, no clear cause can be identified. Such cases of hypertension are described as “essential” or “primary” hypertension. Hypertension may be the first sign of impending pre-eclampsia which is responsible for one sixth of all maternal death. Management of hypertension in pregnancy aims to protect the mother from the effects of high blood pressure, prevent progression of the disease and occurrence of eclamptic convulsions, minimize risks of the foetus, and lastly deliver the foetus when the risk to the mother or foetus, if the pregnancy continues, outweighs the risk of delivery and prematurity. Many pregnant women may be mildly hypertensive (<150/100 mmHg), but treatment may not be required, as they have a low absolute risk of developing pre-eclampsia. Antihypertensive drugs are given to protect the mother –usually against the risk of stroke, although they have a limited effect on the progression of pregnancy induced hypertension or the development of pre-eclampsia. The ultimate treatment of pregnancy induced hypertension and pre-eclampsia is delivery –mainly when the foetus is in enough mature stage for the neonatal care facilities. On the other hand, pregnant women with essential hypertension, at risk of developing pre-eclampsia and intrauterine growth restriction, need close management, including frequent blood pressure checks and assessment of foetal growth and antihypertensive therapy.
Authors and Affiliations
Datta Debranjan*1, Concessao Lavina Preethi2
Keywords
Related Articles
- EP ID EP85998
- DOI -
- Views 123
- Downloads 0
A Bibliometric research on Medicinal and Aromatic Plants: A Core Journal Study.
The a im of the s tudy i s to eva lua t e ant i s e rotone rgi c a c t ivi ty of e thyl a c e t a t e ext r a c t of Abrus precatorius leaves on a frog fundus strip by using sumatriptan as a standa...
Pharmacophore modeling and 3D QSAR studies on N- (2-benzoylphenyl)-L-tyrosines as PPARg Agonists
Three dimensional pharmacophore modeling studies were performed on a diverse set of N-(2-benzoylphenyl)-L-tyrosine derivatives that demonstrate antidiabetic activity by stimulating peroxisome proliferator activated recep...
HPLC Method Development for Glucosamine Sulphate and Diacerein Formulation
A simple, specific, sensitive, and rapid high performance liquid chromatography (HPLC) method for the determination of Glucosamine sulphate and Diacerein for assay was developed. Glucosamine and Diacerein were baseline s...
Comparison of antiinflammatory activity of Artemisia annua leaves extracts obtained through conventional and new method.
In this study, the antiinflammatory activity of Artemisia annua leaves aqueous methanolic extracts (obtained through the Soxhlet and MAE) were studied using carrageenan and egg albumin induced rat paw edema in acute, and...
Emergence of ‘Super Bug’ and Use of Antibiotics: What We Learned, What We Have Yet to Learn?
Recent reports on emergence of a multidrug resistant ‘superbug’ have given the world a warning call against irrational use of antimicrobials. Few examples of most dangerous bugs include MRSA, Klebsiella Penumonia, vancom...